Affiris is a biopharmaceutical company specializing in the research and development of innovative immunotherapies for the treatment of neurodegenerative diseases. With a focus on developing personalized medicines, Affiris aims to revolutionize the treatment of conditions such as Parkinson's disease and Alzheimer's disease. Through cutting-edge technology and a commitment to scientific excellence, Affiris is dedicated to improving the lives of patients and advancing the field of immunotherapy.
This text is generated by artificial intelligence and may not be accurate.
When one googles “prolific inventors,” a list of global inventors is shown. There is no known list of prolific inventors within world cities. IDiyas.com is tracking prolific hyperlocal inventors in a worldwide economy. This site aims to celebrate inventors and their ideas. When two or more inventors start to collaborate, many more innovations are born. IDiyas wants to build an engaging forum for inventors to vet ideas, trends, and commercialization in a safe, trusted environment. Less than 2% of all inventors generate 62% of all Patents.